Last CNY19.28 CNY
Change Today -0.06 / -0.31%
Volume 1.0M
002349 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

nantong jinghua pharmaceu-a (002349) Snapshot

Open
CNY19.33
Previous Close
CNY19.34
Day High
CNY19.33
Day Low
CNY19.00
52 Week High
02/20/14 - CNY21.12
52 Week Low
11/11/13 - CNY11.00
Market Cap
3.9B
Average Volume 10 Days
1.2M
EPS TTM
CNY0.15
Shares Outstanding
200.0M
EX-Date
06/4/14
P/E TM
130.4x
Dividend
CNY0.05
Dividend Yield
0.26%
Current Stock Chart for NANTONG JINGHUA PHARMACEU-A (002349)

Related News

No related news articles were found.

nantong jinghua pharmaceu-a (002349) Related Businessweek News

No Related Businessweek News Found

nantong jinghua pharmaceu-a (002349) Details

Nantong Jinghua Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and trading of active pharmaceutical ingredients (APIs), intermediates, formulations, and traditional Chinese medicines in China and internationally. It provides approximately 200 formulation products in the forms of injection, tablet, capsule, pill, granular, powder, and syrup. The company’s principal APIs include Phenobarbital, Primidone, 5-Fluorouracil, 5-Flucytosine, Phenylbutazone, Piroxicam, Aminoglutethimide, Tenoxicam, Propylthiouracil, Moxonidine HCl, and their intermediates and derivatives. Nantong Jinghua Pharmaceutical Co., Ltd. is based in Nantong, China.

nantong jinghua pharmaceu-a (002349) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nantong jinghua pharmaceu-a (002349) Key Developments

Nantong Jinghua Pharmaceutical Co., Ltd. Declares Final Dividend, Payable on June 04, 2014

Nantong Jinghua Pharmaceutical Co., Ltd. declared cash dividend of CNY 0.50(tax included) per 10 shares for the fiscal year of 2013. The dividend will be payable on June 04, 2014, with a record date of June 03, 2014. The ex-date was June 04, 2014.

Nantong Jinghua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 21, 2014

Nantong Jinghua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 21, 2014., at 14:00 China Standard Time. Agenda: To consider the eligibility for non-public A-share offering; to consider the scheme for non-public share offering in 2014; to consider the preplan for non-public share offering in 2014; to consider the feasibility report on use of proceeds from the non-public share offering; to consider the report on use of previously raised funds (May 2014); to consider the connected transactions involved in the non-public share offering in 2014; to sign the agreement on subscription for shares from 2014 non-public share offering with ten parties; to consider the authorization to the board to handle matters in relation to non-public share offering; and to consider the exemption of Zan Shengda and the person acting in concert from the tender offer obligation.

Nantong Jinghua Pharmaceutical Co., Ltd. to Report Q1, 2014 Results on Apr 11, 2014

Nantong Jinghua Pharmaceutical Co., Ltd. announced that they will report Q1, 2014 results on Apr 11, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002349:CH CNY19.28 CNY -0.06

002349 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002349.
View Industry Companies
 

Industry Analysis

002349

Industry Average

Valuation 002349 Industry Range
Price/Earnings 100.0x
Price/Sales 5.4x
Price/Book 5.9x
Price/Cash Flow 128.0x
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANTONG JINGHUA PHARMACEU-A, please visit www.ntjhzy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.